The healthcare industry continues to be a hotbed of innovation, with activity driven by telemedicine, real-time diagnostics, smart hospitals and access to digital therapies, as well as the growing importance of technologies such as artificial intelligence (AI), the Internet of Things (IoT), augmented reality (AR), robotics and data management practices. In the last three years alone, there have been over 106,000 patents filed and granted in the healthcare industry, according to GlobalData’s report on Personal Health Data in Healthcare: Blood glucose monitoring systems.
According to GlobalData’s Technology Foresights, which uses over 443,000 patents to analyse innovation intensity for the healthcare industry, there are 200+ innovation areas that will shape the future of the industry.
Blood glucose monitoring systems is a key innovation area in personal health data
Blood glucose monitoring systems determine the glucose levels in the blood. It requires a small amount of blood sample which is taken by pricking the fingertip and placing it on a chemically active disposable ‘test-strip’. The development in the field is extended with continuous glucose monitoring systems.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 20+ companies, spanning technology vendors, established healthcare companies, and up-and-coming start-ups engaged in the development and application of blood glucose monitoring systems.
Key players in blood glucose monitoring systems – a disruptive innovation in the healthcare industry
‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to blood glucose monitoring systems
|Company||Total patents (2010 - 2021)||Premium intelligence on the world's largest companies|
|Medtronic||132||Unlock company profile|
|DexCom||97||Unlock company profile|
|F. Hoffmann-La Roche||95||Unlock company profile|
|Bigfoot Biomedical||61||Unlock company profile|
|Fresenius & Co||48||Unlock company profile|
|Aseko||41||Unlock company profile|
|Abbott Laboratories||40||Unlock company profile|
|Beta Bionics||37||Unlock company profile|
|DEKA Research and Development||33||Unlock company profile|
|Becton Dickinson and Co||28||Unlock company profile|
|Masimo||24||Unlock company profile|
|Diabetes Tools Sweden||24||Unlock company profile|
|Sanofi||18||Unlock company profile|
|Qualcomm||14||Unlock company profile|
|Oracle||13||Unlock company profile|
|Novo Nordisk Foundation||12||Unlock company profile|
|Apollo Neuroscience||9||Unlock company profile|
|CEA||9||Unlock company profile|
|Johnson & Johnson||9||Unlock company profile|
|Insulet||8||Unlock company profile|
|PHC Holdings||8||Unlock company profile|
|DreaMed Diabetes||8||Unlock company profile|
|CareFusion 207||7||Unlock company profile|
|Asahi Kasei||7||Unlock company profile|
|Clalit Health Services||5||Unlock company profile|
|Erech Finance Cahalacha||5||Unlock company profile|
Source: GlobalData Patent Analytics
Medtronic is the leading patent filer in the blood glucose monitoring systems. Some other leading patent filers include DexCom and F.Hoffmann-La Roche.
In terms of application diversity, Masimo leads the pack, followed by DexCom and Abbott Laboratories. By means of geographic reach, Sanofi held the top position, followed by CareFusion 207 and Becton Dickinson in second and third spots, respectively.
Blood glucose monitoring is essential for diabetic patients. Blood glucose monitoring systems have already reached an advanced state in terms of accuracy, cost-effectiveness and convenience. The companies are now focused on improving the interface and mobile device compatibility. Further research is being conducted on biosensing technologies which use biological fluids to be calibrated and used to evaluate correct blood glucose concentrations.
To further understand the key themes and technologies disrupting the healthcare industry, access GlobalData’s latest thematic research report on Personal health data - 2021.